Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07856121) titled 'The Precision Mito- Mito Map COMPASS Study' on Sept. 24.
Study Type: Observational
Primary Sponsor: AI Agent Vault, Inc. d/b/a Precision Mito
Condition:
Mitochondrial Diseases
Myalgic Encephalomyelitis Chronic Fatigue Syndrome
Post-COVID-19 Condition
Postural Orthostatic Tachycardia Syndrome
Lyme Disease
Post-Treatment Lyme Disease Syndrome
Fibromyalgia
Cancer-Related Fatigue
Neuromuscular Diseases
Fatigue
POLG-Related Disorders
Intervention:
Other: Mito Map Energy Score and Home Functional Assessments
Recruitment Status: Not recruiting
Date of First Enrollment: November 1, 2026
Target Sample Size: 400
Coun...